White blood cell DNA adducts, smoking, and NAT2 and GSTM1 genotypes in bladder cancer: A case-control study

Cancer Epidemiology Biomarkers and Prevention

Volumn 7, Issue 4, 1998, Pages 341-346

  Peluso, Marco ^a   Airoldi, Luisa ^b   Armelle, Munnia ^a   Martone, Tiziana ^c   Coda, Renato ^d   Malaveille, Christian ^e   Giacomelli, Giuseppe ^d   Terrone, Carlo ^f   Casetta, Giovanni ^g   Vineis, Paolo ^c  

^a UNIVERSITY OF GENOA   (Italy)

^b MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^c UNIVERSITY OF TURIN   (Italy)

^d GRADENIGO HOSPITAL   (Italy)

^e INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^f UNIVERSITY OF TURIN   (Italy)

^g MOLINETTE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLTRANSFERASE; GLUTATHIONE TRANSFERASE; TOBACCO SMOKE;

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER RISK; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA ADDUCT; GENOTYPE; HUMAN; HUMAN CELL; ITALY; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REGRESSION ANALYSIS; SMOKING HABIT;

ADULT; AGED; ARYLAMINE N-ACETYLTRANSFERASE; CASE-CONTROL STUDIES; DNA ADDUCTS; GENOTYPE; GLUTATHIONE TRANSFERASE; HUMANS; ITALY; LEUKOCYTES; MALE; MIDDLE AGED; SMOKING; URINARY BLADDER NEOPLASMS;

EID: 7344242589     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. IARC. Tobacco Smoking. Monographs on the evaluation of the carcinogenic risk of chemicals to humans. IARC Sci. Publ, 38: 1-421, 1986.
2. D'Avanzo, B., Negri, E, La Vecchia, C., Gramenzi, A, Bianchi, C., Franceschi, S., and Boyle, P. Cigarette smoking and bladder cancer Eur. J. Cancer, 26: 714-718, 1990.
3. Vineis, P., Esteve, J , Hange, P., Hoover, R., Silverman, D T , and Terracini, B Effects of the timing and type of tobacco in cigarette-induced bladder cancer. Cancer Res., 48: 3849-3852, 1988
4. Iscovich, J., Castelleto, R., Esteve, J , Munoz, N., Colanzi, R., Coronel, A., Deamezola, I., Tassi, V., and Arslan, A. Tobacco smoking, occupational exposure, and bladder cancer in Argentina. Int. J. Cancer, 40: 734-740, 1987
5. Clavel, J., Cordier, S., Boccon-Gibod, L , and Hemon, D. Tobacco and bladder cancer in males increased risk for inhalers and black tobacco smokers. Int J. Cancer, 44: 605-610, 1989.
6. IARC. Overall evaluation of carcinogenicity: an updating of IARC monographs 1 to 42. Monographs on the evaluation of the carcinogenic risk of chemicals to humans. IARC Sci. Publ., Suppl 7: 1-440, 1987.
7. Patrianakos, C , and Hoffman, D. Chemical studies of tobacco smoke. LXIV On the analysis of aromatic amines in cigarette smoke. J. Anal Chem., 3: 150-154, 1979.
8. Bryant, M S., Vineis, P , Skipper, P, and Tannenbaum, S. R. Hemoglobin adducts of aromatic amines: associations with smoking status and type of tobacco. Proc. Natl. Acad. Sci. USA, 85: 9788-9791, 1988.
9. Skipper, P. L., and Tannenbaum, S R. Protein adducts in the molecular dosimetry of chemical carcinogens. Carcinogenesis (Lond.), 11 507-518, 1990.
10. Malaveille, C., Vineis, P., Esteve, J., Ohshima, H., Brun, G., Hautefeuille, A, Gallet, P., Ronco, G , Terracini, B., and Bartsch, H. Levels of mutagens in the urine of smokers of black and blonde tobacco correlate with their risk of bladder cancer Carcinogenesis (Lond.), 10, 577-586, 1989
11. Butler, M. A., Iwasaki, M., Guengerich, F. P., and Kadlubar, F. F. Human cytochrome P450 PA (P450 IA2), the phenacetin O-deethylase is primarily responsible for the hepatic 3-demethylation of caffeine and the N-oxidanon of carcinogenic arylamines. Proc Natl Acad Sci. USA, 86: 7696-7700, 1989.
12. Beland, F A., and Kadlubar, F. F. Factors involved in the induction of bladder cancer by aromatic amines. Banbury Rep , 23. 315-326, 1986.
13. Weber, W. W. The Acetylator Genes and Drug Response, pp 32-48. Oxford: Oxford University Press. 1987.
14. Hein, D. W. Acetylator genotype and arylamine-induced carcinogenesis. Biochim Biophys. Acta, 945: 37-66, 1988
15. Cartwright, R. A , Ahmad, R. A , Barham-Hall, D., Glashan, R. W , Rogers, H. J., Higgins, E., and Kahn, M A. Role of N-acetyltransferase phenotypes in bladder carcinogenesis: a pharmacogenetic epidemiologic approach to bladder cancer. Lancet, 2: 842-845, 1982.
16. Evans, D. A. P , Eze, L. C , and Whibley, E. J. The association of the slow acetylator phenotype with bladder cancer. J. Med Genet., 20: 330-333, 1983.
17. Mommsen, S., and Aagaard, J Susceptibility in urinary bladder cancer: acetyltransferase phenotypes and related risk factors Cancer Lett , 32: 199-205, 1986
18. Schulte, P. A. The role of genetic factors in bladder cancer. Cancer Detect. Prev, 11: 379-388, 1988.
19. Vineis, P., Caporaso, N., Tannenbaum, S., Skipper, P, Glogowski, J, Bartsch, H., Coda, M., Talaska, G., and Kadlubar, F. The acetylation phenotype, carcinogen-hemoglobin adducts. and cigarette smoking. Cancer Res., 50 3002-3004, 1990.
20. 32P-Postlabeling detection of DNA adducts in peripheral white blood cells of greenhouse floriculturists from Western Liguna, Italy. Cancer Epidemiol Biomark. Prev , 5: 361-369, 1996
21. Bolognesi, C., Peluso, M., Degan, P., Rabboni, R., Munnia, A., and Abbondandolo, A. Genotoxic effects of the carbamate insecticide, methomyl. II. In vivo studies with pure compound and the technical formulation, Lannate 25, Environ. Mol. Mutagen., 24: 235-242, 1994.
22. 32Postlabelling analysis of urinary mutagens from smokers of black tobacco implicates 2-amino-1-methyl-6-phenyhmidazo[4,5-b]pyridine (PhIP) as a major DNA-damaging agent. Carcinogenesis (Lond.), 12: 713-717, 1991.
23. Taningher, M., Peluso, M , Parodi, S , Ledda, C. G M., and Columbano, A Genotoxic and non-genotoxic activities of 2,4- and 2,6-diaminotoluene, as evaluated in Fisher-344 rat liver. Toxicology, 99: 1-10, 1995.
24. 32P-postlabeling and enzyme-linked immunosorbent assay Environ. Health Perspect., 99: 307-309, 1993.
25. Bell, D. A., Taylor, J. A., Butler, M A., Stephens, E. A., Wiest, J., Brubaker, D. H., Kadlubar, F. F., and Lucier, G. W. Genotype/phenotype discordance for human N-acetyltransferase (NAT2) reveals a new slow-acetylator allele common in African-Americans. Carcinogenesis (Lond.), 14: 1689-1692, 1993
26. Fryer, A. A., Zhao, L , Alldersea, J , Pearson, W. R., and Strange, R. C. Use of site-directed mutagenesis of allele-specific PCR primers to identify the GSTM1A, GSTM1B, GSTM1A, B and GSTM1 null polymorphisms of the glutathione-S-transferase GSTM1 locus. Biochem J , 295. 313-315, 1993.
27. Vineis, P., Bartsch, H., Caporaso, N., Harrington, A M., Kadlubar, F F., Landi, M T, Malaveille, C., Shields, P., Skipper, P., Talaska, G., and Tannenbaum, S. R. Genetically-based N-acetyltransferase metabolic polymorphism and low-level environmental exposure to carcinogens. Nature (Lond.), 369: 154-156, 1994.
28. IARC. Tobacco smoking Monographs on the evaluation of carcinogenic risk to humans. IARC Sci Publ., 38: 83-126, 1986.
29. Miller, E. C., and Miller, J. A. Searches for ultimate chemical carcinogens and their reactions with cellular macromolecules Cancer (Phila.), 47: 2327-2345, 1981.
30. 32P-Adduct assay: comparative recoveries of structurally diverse DNA adducts in the vanous enhancement procedures. Carcinogenesis (Lond.), 9. 1687-1693, 1988.
31. Phillips, D. H., Hewer, A., Martin, C N., Garner, R. C., and King, M. M. Correlation of DNA adduct levels in human lung with cigarette smoking. Nature (Lond.), 336. 22-29, 1988.
32. 32P-postlabeling assay. J. Natl. Cancer Inst., 81: 341-347, 1989.
33. 32P-postlabeling analysis. Carcinogenesis (Lond.), 18. 339-334, 1997.
34. Talaska, G., Schamer M , Skipper, P., Tannenbaum, S., Caporaso, N , Unruh, L., Kadlubar, F. F., Bartsch, H., Malaveille, C., and Vineis, P. Detection of carcinogen-DNA adducts in exfoliated urothelial cells of cigarette smokers. association with smoking, hemoglobin adducts, and urinary mutagenicity. Cancer Epidemiol Biomark. Prev., 1: 61-66, 1991.
35. 32P-postlabeling assay Carcinogenesis (Lond.), 13: 1053-1074, 1992.
36. Wiencke, J K , Kelsey, K. T., Varkonyi, A , Semey, K., Wain, J. C., Mark, E., and Christiani, D C Correlation of DNA adducts in blood mononuclear cells with tobacco carcinogen-induced damage in human lung. Cancer Res., 55: 4910-4914, 1995
37. Nielsen, P. S., de Pater, N., Okkels, H., and Autrup H. Environmental air pollution and DNA adducts in Copenhagen bus drivers: effect of CSTM1 and NAT2 genotypes on adduct levels. Carcinogenesis (Lond.), 17. 1021-1027, 1996
38. Phillips, D., Schoket, B., Hewer, A , Bailey, E, Kostic, S, and Vincze, I. Influence of cigarette smoking on the levels of DNA adducts in human bronchial epithelium and white blood cells. Int. J. Cancer, 46: 569-575, 1990
39. Savela, K., and Hemminki, K DNA adducts in lymphocytes and granulocytes of smokers and nonsmokers detected by the 32-P-postlabelling assay, Carcinogenesis (Lond.), 12: 503-508, 1991.
40. Jahnke, G. A., Thompson, C. L., Walker, M. P., Gallagher, J. E., Lucier, G W , and Di Augustine, R P Multiple DNA adducts in lymphocytes of smokers and nonsmokers determined by 32-P-postlabelling analysis Carcinogenesis (Lond.), 11: 205-211, 1990.
41. Perera, F P. Molecular epidemiology: insights into cancer susceptibility, risk assessment, and prevention. J. Nad. Cancer Inst., 88: 496-507, 1996
42. Sinopoli, N. T., Trivers, G E., Ficorella, C., Tomao, S., Martelli, M., Cagnazzo, P., Sama, N., Hams, C. C., and Fratl. L. Immunoassay detection of carcinogen-DNA adducts in tumor and noninvolved lung tissue from lung cancer patients. Proc. Am Assoc. Cancer Res, 31: 97, 1990.
43. Tang, D., Santella, R. M., Blackwood, A. M., Young, T L., Mayer, S, Jaretzki, A, Grantham, S., Tsai, W Y., and Perera, F. A molecular epidemiological case-control study of lung cancer Cancer Epidemiol. Biomark Prev., 4. 341-346, 1995.
44. Pfohl-Leszkowicz, A., Grosse, Y., Carriere, V., Cugnenc, P. H, Berger, A., Caraot, F., Beaune, P., and De Wasiers, I. High levels of DNA adducts in human colon are associated with colorectal cancer Cancer Res., 55: 5230-5237, 1995.
45. D'Errico, A., Taioli, E., Chen, X., and Vineis, P Genetic metabolic polymorphisms and the risk of cancer: a review of the literature. Biomarkers, 1. 149-173, 1996.
46. Ichiba, M, Hagmar, L., Rannug, A , Hogstedt, B., Alexandrie, A. K., Carstensen, V., and Hemminki, K. Aromatic DNA adducts, micronuclei and genetic polymorphism for CYP1A1 and GST1 in chimney sweeps. Carcinogenesis (Lond.), 15: 1347-1352, 1994.
47. Hou, S. M., Lambert, B., and Hemminki, K. Relationship between hrpt mutant frequency, aromatic DNA adducts and genotypes for GSTM1 and NAT2 in bus maintenance workers. Carcinogenesis (Lond.), 16: 1913-1917, 1995.
48. Perera, F. P. Molecular epidemiology, insights into cancer susceptibility, risk assessment, and prevention. J. Natl. Cancer Inst., 88. 496-509, 1996.